Preimplantation Genetic Testing
PGT-A
Preimplantation Genetic Testing for Aneuploidy
Overview
PGT-A (Preimplantation Genetic Testing for Aneuploidy) is an advanced genetic test performed on embryos created through IVF. By screening embryos for chromosomal abnormalities before implantation, PGT-A significantly improves IVF success rates and reduces the risk of miscarriage.
Up to 70%
IVF Success Rate
Reduced 50%
Miscarriage Risk
All 24
Chromosomes
NGS-Based
Technology
Benefits of PGT-A
Higher IVF Success
Select chromosomally normal embryos for transfer, significantly improving implantation rates
Reduced Miscarriage
Eliminate embryos with chromosomal abnormalities that commonly cause early pregnancy loss
Shorter Time to Pregnancy
Fewer IVF cycles needed by transferring only viable embryos
Informed Decisions
Empower patients with comprehensive genetic information about their embryos
How It Works
IVF Cycle
Eggs are retrieved and fertilized to create embryos
Embryo Biopsy
A few cells are carefully removed from each embryo at the blastocyst stage
Genetic Analysis
Cells are analyzed using next-generation sequencing technology
Embryo Transfer
Only chromosomally normal embryos are selected for transfer
Frequently Asked Questions
Who should consider PGT-A?
Does the biopsy harm the embryo?
How long does it take to get results?
Is PGT-A covered by insurance?
Can PGT-A detect all genetic conditions?
Improve Your IVF Success
Speak with our specialists about PGT-A for your fertility journey
Schedule a Consultation